Effect of Cholesteryl Esters on PS1 and on ABeta Ratios
About the Research Project
Program
Award Type
Standard
Award Amount
$200,000
Active Dates
April 01, 2001 - March 31, 2003
Grant ID
A2001047
Summary
High cholesterol levels have long been associated with atherosclerosis. Recent studies show that high cholesterol levels are also linked to the increased appearance of the senile plaques and neurofibrillary tangles characteristic of Alzheimer’s disease. One possible explanation is that cholesterol inside the cellular membranes may somehow regulate the enzymes (secretases) that generate the amyloid beta peptide found in senile plaques. The cholesterol content in cellular membranes is maintained by the action of an enzyme called ACAT, which moves excess cholesterol from the membrane into the cell’s cytoplasm in the form of insoluble lipid droplets. In earlier work, Dr. Kovacs found that decreased lipid droplets led to a decrease in the production of amyloid beta, whereas abnormally high levels of lipid droplets (even with normal membrane cholesterol levels) led to an increase in amyloid beta production. Dr. Kovacs suggests that the mechanism for this may involve the stabilization of presenilins, Alzheimer-associated proteins responsible for the production of amyloid beta. Dr. Kovacs is now exploring the mechanism by which presenilin activity and the production of amyloid beta may be regulated by lipid droplets. Understanding this mechanism could provide the basis for developing ACAT inhibitors that would lower amyloid beta generation and slow or prevent AD-related neuropathology.
Related Grants
Alzheimer's Disease Research
The Effects of Peripheral APOE2 on Alzheimer’s Disease Pathology and Pathways
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Guojun Bu, PhD
Current Organization
Hong Kong University of Science and Technology
The Effects of Peripheral APOE2 on Alzheimer’s Disease Pathology and Pathways
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Guojun Bu, PhD
Current Organization
Hong Kong University of Science and Technology
Alzheimer's Disease Research
Dysfunction of the Regulation of Cerebral Blood Flow in Alzheimer Disease
Active Dates
July 01, 2022 - June 30, 2025
Principal Investigator
Antoine Anfray, PhD
Current Organization
Weill Medical College of Cornell University
Dysfunction of the Regulation of Cerebral Blood Flow in Alzheimer Disease
Active Dates
July 01, 2022 - June 30, 2025
Principal Investigator
Antoine Anfray, PhD
Current Organization
Weill Medical College of Cornell University
Alzheimer's Disease Research
Abca1 Regulates Lipid Metabolism and Tau Pathology in P301S/ApoE4 Mice
Active Dates
July 01, 2022 - June 30, 2024
Principal Investigator
Alexandra Litvinchuk, PhD
Current Organization
Washington University in St. Louis
Abca1 Regulates Lipid Metabolism and Tau Pathology in P301S/ApoE4 Mice
Active Dates
July 01, 2022 - June 30, 2024
Principal Investigator
Alexandra Litvinchuk, PhD
Current Organization
Washington University in St. Louis